Form D · Other Technology

NexHealth, Inc.

San Francisco, CA · CIK 0001682508

Offering snapshot reported May 19, 2022 · SEC filing

Reported sold
$127M
Offering amount: $127M
Investors reported
26
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 13, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 19, 2022Initial$127,324,891No comparison26SEC filing
Jul 8, 2021Initial$30,874,901No comparisonNot reportedSEC filing
Jul 30, 2020Initial$12,221,995No comparison20SEC filing
Jul 30, 2020Initial$12,221,995No comparison20SEC filing
Sep 20, 2019Initial$3,250,706No comparison7SEC filing
Sep 9, 2016Initial$1,150,000No comparison2SEC filing
Aug 24, 2016Initial$390,998No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-446295
The total offering amount and amount sold includes $870,000.00 representing the conversion of oustanding convertible securities.

Source: Form D, filed May 19, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Waleed Asif Director
Joshua Buckley Director
Christoph Janz Director
Adam Lin Director
Alamin Uddin Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
333 Bush Street 20th Floor
San Francisco, CA, 94104